| 1. |
Allert, Catana: Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML. -
London: Nature Publishing Group, 2022
In: Leukemia. (2022) S. 2418-2429, ISSN 0887-6924
 Zeitschriftenartikel |
|
|
| 2. |
Stelmach, Patrick: Clonal hematopoiesis with DNMT3A and PPM1D mutations impairs regeneration in autologous stem cell transplant recipients. -
Italy: Ferrata Storti Foundation, 2023
In: Haematologica (Roma). (2023) S. 3308-3320, ISSN 0390-6078
Zeitschriftenartikel |
|
|
| 3. |
He, Lixiazi: CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia. -
England: EMBO Press, 2022. - 22 S.
In: EMBO molecular medicine. (2022) S. e14990-n/a, ISSN 1757-4676
Zeitschriftenartikel |
|
|
| 4. |
Neuendorff, Nina Rosa: Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myeloma. -
Switzerland: Frontiers Media S.A, 2023
In: Frontiers in oncology. (2023) S. 1168120-1168120, ISSN 2234-943X
Zeitschriftenartikel |
|
|
| 5. |
Maurus, Johannes: Validation of a proxy‐reported SARC‐F questionnaire for current and retrospective screening of sarcopenia‐related functional impairments. -
Germany: John Wiley & Sons, Inc, 2022. - 12 S.
In: Journal of cachexia, sarcopenia and muscle. (2022) S. 264-275, ISSN 2190-5991
Zeitschriftenartikel |
|
|
| 6. |
Renders, Simon: P408: COMBINATORIAL BCL‐2 FAMILY EXPRESSION IN ACUTE MYELOID LEUKEMIA STEM CELLS PREDICTS CLINICAL RESPONSE TO AZACITIDINE/VENETOCLAX. -
Philadelphia, PA: Lippincott Williams & Wilkins, 2023. - 2 S.
In: HemaSphere. (2023) S. e33925b8-n/a, ISSN 2572-9241
Zeitschriftenartikel |
|
|
| 7. |
Pabst, Caroline: Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell Transplantation. -
Switzerland: MDPI AG, 2022
In: Vaccines (Basel). (2022) S. 330, ISSN 2076-393X
Zeitschriftenartikel |
|
|
| 8. |
Janssen, Maike: Misslingensbedingungen einer Plattformintegration. Rekonstruktion eines Software-Entwicklungsprozesses für das Universitätskrankenhaus. -
Stuttgart: De Gruyter, 2022. - 29 S.
In: Soziale Systeme. (2022) S. 313-341, ISSN 0948-423X
Zeitschriftenartikel |
|
|
| 9. |
Janssen, Maike: Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1. -
United States: Elsevier Inc, 2022
In: Blood. (2022) S. 2594-2610, ISSN 0006-4971
Zeitschriftenartikel |
|
|
| 10. |
Janssen, Maike: Donor derived HLA-G polymorphisms have a significant impact on acute rejection in kidney transplantation. -
United States: Elsevier Inc, 2019
In: Human immunology. (2019) S. 176-183, ISSN 0198-8859
Zeitschriftenartikel |
|
|
| 11. |
Waclawiczek, Alexander: Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax. -
United States: American Association for Cancer Research, 2023
In: Cancer discovery. (2023) S. 1408-1427, ISSN 2159-8274
Zeitschriftenartikel |
|
|
| 12. |
Beneyto-Calabuig, Sergi: Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia. -
United States: Elsevier Inc, 2023
In: Cell stem cell. (2023) S. 706-721.e8, ISSN 1934-5909
Zeitschriftenartikel |
|
|
| 13. |
Renders, Simon: Macs - a Leukemic Stem Cell- Based Predictor of Clinical Response to Venetoclax and Other BH3 Mimetics for Acute Myeloid Leukemia: Elsevier Inc, 2022
In: Blood. (2022) S. 2023-2024, ISSN 0006-4971
Zeitschriftenartikel |
|
|
| 14. |
Janssen, Maike: Treatment of chronic COVID‐19 with convalescent/postvaccination plasma in patients with hematologic malignancies. -
Hoboken, USA: John Wiley & Sons, Inc, 2024. - 9 S.
In: International journal of cancer. (2024) S. 618-626, ISSN 0020-7136
Zeitschriftenartikel |
|
|
| 15. |
Weidenauer, Katharina: The ribosomal protein S6 kinase alpha-1 (RPS6KA1) induces resistance to venetoclax/azacitidine in acute myeloid leukemia. -
England: Nature Publishing Group, 2023
In: Leukemia. (2023) S. 1611-1625, ISSN 0887-6924
Zeitschriftenartikel |
|
|
| 16. |
Liu, Yi: CD33‐directed immunotherapy with third‐generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33‐edited acute myeloid leukemia and hematopoietic stem and progenitor cells. -
Hoboken, USA: John Wiley & Sons, Inc, 2022. - 15 S.
In: International journal of cancer. (2022) S. 1141-1155, ISSN 0020-7136
Zeitschriftenartikel |
|
|
| 17. |
Renders, Simon: Leukemic Stem Cells of Monocytic AMLs Are Not-Resistant to BCL-2 Inhibition: Elsevier Inc, 2021
In: Blood. (2021) S. 3469-3469, ISSN 0006-4971
Zeitschriftenartikel |
|
|
| 18. |
Thude, Hansjörg: 14-bp ins/del polymorphism and +3142C>G SNP of the HLA-G gene have a significant impact on acute rejection after liver transplantation. -
United States: Elsevier Inc, 2016
In: Human immunology. (2016) S. 1159-1165, ISSN 0198-8859
Zeitschriftenartikel |
|
|
| 19. |
Unglaub, Julia M.: Venetoclax-Based Salvage Therapy Improves Outcome in Relapsed/Refractory AML Patients Eligible for Intensive Treatment: A Propensity Score Matching Analysis: Elsevier Inc, 2022
In: Blood. (2022) S. 3317-3319, ISSN 0006-4971
Zeitschriftenartikel |
|
|
| 20. |
Unglaub, Julia M.: Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study: Elsevier Inc, 2021
In: Blood. (2021) S. 4418-4418, ISSN 0006-4971
Zeitschriftenartikel |
|
|
Suchhistorie (1 Recherche)
[1-20]
[21-24]
Jahr
